Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.44 is 38% below its 5-year average of 15.27, near the low end of its 5-year range (8.43–64.07).
As of the fiscal period ended Tuesday, June 30, 2026. 31.57% below its 12-month average of 13.80.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 9.44.
CURRENT RATIO
9.44
CURRENT RATIO AVG TTM
13.80
CURRENT RATIO AVG 3Y
12.66
CURRENT RATIO AVG 5Y
15.27
CURRENT RATIO AVG 10Y
9.00
CURRENT RATIO AVG 15Y
6.71
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-31.57%
CURRENT VS 3Y AVG
-25.45%
CURRENT VS 5Y AVG
-38.18%
CURRENT VS 10Y AVG
+4.87%
CURRENT VS 15Y AVG
+40.62%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+151.77%
vs the sector median at left
Market Cap
$404.94M
Current Ratio
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
Market Cap
$409.29M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$409.69M
Current Ratio
2.64
TTM Avg
6.72
3Y Avg
6.86
5Y Avg
10.11
Market Cap
$396.93M
Current Ratio
10.71
TTM Avg
7.83
3Y Avg
8.94
5Y Avg
8.94
Market Cap
$412.91M
Current Ratio
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $409.72M | 9.44 | 13.80 | 12.66 | 15.27 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.94M | 8.13 | 16.34 | 21.67 | 17.16 |
| Neurogene Inc. (NGNE)vs › | $402.01M | 10.64 | 18.70 | 14.71 | 15.05 |
| Myriad Genetics, Inc. (MYGN)vs › | $405.49M | 2.21 | 2.16 | 2.08 | 2.23 |
| Carlsmed, Inc. (CARL)vs › | $401.25M | 8.84 | 7.23 | 5.35 | 5.35 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $409.29M | 9.89 | 6.34 | 6.34 | 6.34 |
| Strata Critical Medical, Inc. (SRTA)vs › | $409.69M | 2.64 | 6.72 | 6.86 | 10.11 |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | 10.71 | 7.83 | 8.94 | 8.94 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.91M | 16.52 | 13.61 | 8.86 | 8.86 |
| Prothena Corporation plc (PRTA)vs › | $417.78M | 25.05 | 8.87 | 10.83 | 12.06 |
Current Ratio
9.44
Quick Ratio
9.44
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.44 |
| 2026-03-31 | 15.84 |
| 2025-12-31 | 14.18 |
| 2025-09-30 | 15.15 |
| 2025-06-30 | 14.37 |
| 2025-03-31 | 8.43 |
| 2024-12-31 | 9.30 |
| 2024-09-30 | 13.79 |
| 2024-06-30 | 13.39 |
| 2024-03-31 | 11.82 |
| 2023-12-31 | 12.00 |
| 2023-09-30 | 14.27 |
| 2023-06-30 | 20.18 |
| 2023-03-31 | 24.05 |
| 2022-12-31 | 23.38 |
| 2022-09-30 | 64.07 |
| 2022-06-30 | 61.78 |
| 2022-03-31 | 22.35 |
| 2021-12-31 | 12.12 |
| 2021-09-30 | 14.76 |
| 2021-06-30 | 21.34 |
| 2021-03-31 | 8.97 |
| 2020-12-31 | 13.95 |
| 2020-09-30 | 2.36 |
| 2020-06-30 | 3.26 |
| 2020-03-31 | 4.01 |
| 2019-12-31 | 3.60 |
| 2019-09-30 | 4.69 |
| 2019-06-30 | 1.45 |
| 2019-03-31 | 2.32 |
| 2018-12-31 | 0.14 |
| 2018-09-30 | 0.11 |
| 2018-06-30 | 0.32 |
| 2018-03-31 | 0.10 |
| 2017-12-31 | 0.52 |
| 2017-09-30 | 2.58 |
| 2017-06-30 | 2.78 |
| 2017-03-31 | 2.40 |
| 2016-12-31 | 2.27 |
| 2016-09-30 | 2.51 |
| 2016-06-30 | 2.60 |
| 2016-03-31 | 0.84 |
| 2015-12-31 | 0.74 |
| 2015-09-30 | 1.56 |
| 2015-06-30 | 3.59 |
| 2015-03-31 | 4.97 |
| 2014-12-31 | 3.68 |
| 2014-09-30 | 5.26 |
| 2014-06-30 | 6.54 |
| 2014-03-31 | 2.09 |
| 2013-12-31 | 0.28 |
| 2013-09-30 | 0.10 |
| 2013-06-30 | 0.15 |
| 2013-03-31 | 0.25 |
| 2012-12-31 | 0.00 |
| 2012-09-30 | 0.03 |
| 2012-06-30 | 0.45 |
| 2012-03-31 | 0.78 |
| 2011-12-31 | 2.70 |
| 2011-09-30 | 4.27 |
| 2010-12-31 | 0.00 |
